Purpose: The AY-9944 (AY)-treated rat is a reproducible and clinically relev:int aninuil model of atypical absence seizures. AY inhihils cholesterol synthesis, but the relation hetween bruin sterol levels and the spontaneously recurrent absence seizures has not been determined.
Administration of the cholesterol biosynthesis inhibitor, AY-9944 (AY), to suckling Long-Evans hooded rats leads to pennanent and spontatieously recurrent atypical absence seizures (I). Tbis seizure model is unique because the iclal manifestation of tbe AY seizures is atypical and correlates with the occurrence of cortical. ihalamic. and hippocampal slow spike-and-wuve discharges (SWDs) from postnatal day (P)2I onward (1, 2) . Thus the AY model is distinct from tbe GAERS and WAG/Rij rat strains, which are two well-characterized spontaneous genetic models of typical absence epilepsy (3, 4) .
To date, the AY model is the only developmental ly induced long-term model of atypical absence seizures in rats and mice (1, 5) , However, the mechatiism by which AY induces these seizures is unknown. AY inhibits A7-reductase. thereby blocking the conversion of 7-dehydrocholesterol to cholesterol (6) . We are unaware of any studies reporting brain sterol changes after the AY protocol associated with absence seizures. Therefore, the objective of this study was to establish whether there was any relation between changes in brain sterols and the AY-induced seizures. In the three experiments described here, we have continued to use the Long-Evans hooded rat strain because of its intrinsic susceptibility to AYinduced seizures, a feature we have previously commented on in detail (1).
MATERIALS AND METHODS

The AY model
Untimed pregnant Long-Evans hooded rats were obtained from Charles River (St-Constant, Quebec, Canada) and housed at the animal facility at the Hospital for Sick Children (Toronto, Ontario. Canada). The suckling rats were weaned at P21 and then hotised in groups of three animals of the same gender, until the day of surgery for electrode implantation. All animals were maintained in a controlled environment at 12-h light, 12-h dark cycle with lights on at 0600 h. They were given ad lib access to food and water. AY-9944 (tran.s-1.4-bis [2-cIoro-benzyIaminomethyl] cyclohexane dihydrochloride) was a gift frotii Wyeth-Ayerst {Philadelphia. PA, U.S.A.) and was administered subcutaneously at a dose of 7,5 mg/kg, with saline as the vehicle.
Three groups of experiments were done. In experiment 1, the regional analysis of sterols in brain was performed. Rats were injected either with AY (n = 10) or the equivalent volume of saline (controls, n = 10) every 6 days from P2 to P20. The principal brain regions were then dissected before sterol analysis. In experiment 2, we sought to determine the sustainability of the seizures and sterol changes induced by AY over time. Two AY rats were maintained for 400 days after the last AY injection at P20, In experiment 3. we ascertained gender differences in AY-induced alterations in sterols in brain, blood, and liver. The seizure and sterol responses of male (n = 6) or female (n = 5) rats to the same AY protocol were examined.
Surgery and electrocorticography (ECoG)
Before electrode implantation, anesthesia was achieved with a single i.p. injection of pentobarbita! (PTB; 35 mg/kg). which lasted for i.5-2 h. Surgeries consisted of permanent irnplantation of two frontal and two parietal monopolar epidural electrodes and were done at P50. at which time the average body weight was 250-350 g for males and 200-300 g for females. Electrodes were secured with dental cement, and two screws previously attached to the parietal regions of the scalp without touching the dura mater (7) . To define the source and extent of the SWD in the AY model, two frontal monopolar electrodes were placed 1 mm deep, 2,20 mm anterior to bregma. and 3 mm lateral from midline. Referential, unilateral left and right bipolar, and linked monopolar recordings from ipsilateral regions were compared to determine the phase relation, amplitudes, and source of the SWD (3). After surgery, animals were returned to the animal facility for a 4-day recovery period.
On the day of recordings (P55), the rats were freely moving in individual, warm Plexiglas chambers (Harvard Apparatus. Holliston. MA, U.S.A.). A 20-min adaptation period before ECoG recordings miniriiized movement artifact. ECoG recordings were made on paper by using a Grass Polysomnogtaph (Grass Instruments. Quincy, MA, U.S.A,). All baseline and test recordings were performed from 10:00 to 14:00 h to minimize circadian variations (8),
Brain lipid analysis
Immediately after the ECoGs, the rats used for brain sterol analysis were killed with PTB (35 mg/kg), and the brains quickly removed. In experiments 1 and 2, brains were dissected into five separate regions: cortex, thalamus, hippocampus, brainstem, and ceiebellum. In experiment 3, plasma, brain, and liver were collected. Tissue or plasma samples were homogenized in an equal volume of saline, and total lipids were extracted by using 20 volumes of 2:1 chlorofonn: methanol. For fatty acid analysis of brain phospholipids. fatty acid methyl esters were prepared by using boron trifiuoride in methanol. as previously described (9) . Fatty acid analysis was done by capillary gas chromatography on a 30-m column (9,10). Brain total phospholipids were quantified during fatty acid analysis by using an internal standard, heptadecanoic acid, which was added at the stage of total lipid extraction. Tissue sterols were obtained after saponification of the total lipid extracts in IN methanolic KOH. Sterols were derivatized by using tert-butyldimethylsilyl chloride, and analyzed with capillary gas chromalography using 5-a-choIestane as an internal standard.
Data analysis
AY-induced absence seizures were quantified by measuring SWD duration from onset to offset for three consecutive 20-min periods (II). SWDs were scoied in each animal only if two frontal and parietal ECoGs demonstrated the distinct 5-H7 SWD morphology with at least a fourfold higher amplitude cotnpared with control (12) . All seizure data are expressed as the arithmetic mean ± standard error of mean (SEM). Brain lipid data are expressed as the mean ± SD. Comparison of means between two groups were done by two-tailed Student's / test. Anaiysis of variance {ANOVA) for repeated measures was used to quantify the amplitude differences between ECoG baseline, spontaneous bursts, and SWDs as a function of AY and time after injection. Effectiveness for age pairing results was evaluated statistically by using the nonparametric Spearman correlation test., with a probability value of p < 0,05 chosen as an index of statistical significance.
RESULTS
Electrocorticography characteristics of AY seizures
At P55, AY-induced spontaneously recurrent SWDs lasted for 1,447 ± 303 s/h and had a mean amplitude of 465 ± 99 | JLV compared with 25 ± 26 s/h and 142 ± 70 fiV, respectively, in controls (Fig. lA) , proved to be a robust and long-lived phenomenon that became more severe with aging. Four hundred days after the last AY injection at P20. AY-induced SWDs lasted twice as long as those recorded at P55 in the same animals (2,980 s/h; p< 0.0005; Fig, IB) , Brain lipids Capiihiry ga.s chromatograms showed two distinct features in AY-treated rats: a smaller cholesterol peak compared with controls and an additional 7-dehydrocholesterol peak, which was not detected in controls (Fig. 2) .
In experiment I, brain cholesterol in controls was 15-17 mg/g in all regions except the brain.stem, in which it was 22 nig/g. Cholesterol was reduced in all separated brain regions (cerebral cortex, hippocampus, thalamus. cerebellum, and brainstem) by an average of 39^2% or from -16 mg/g to -10 mg/g in AY-9944-treated rats (all values of p< 0.0001; Fig. 3A ). 7-Dehydrocholesterol was increased from undetectable levels lo -4.5 mg/g in all legions except the brainstcm. where it was 7.6 mg/g (p<0.01; Fig. 3B ).
Brain phospholipid concentration remained unchanged after AY treatment, so the cholesterol/ phospholipid ratio in AY-9944 subjects was reduced by .^6-40%. Fatty acid profiles were unaffected by AY-9944 in all of the five brain regions examined (data not shown). Four hundred days after discontinuing AY (experiment 2), brain sterols had returned to normal levels (Fig. 3) . AY had a similar effect on brain, liver, and plasma sterols in male and female rats (Table I) . In experiment 3. AY reduced tissue and plasma cholesterol and increased 7-dchydrocholesterol in bolh males and females, but the 7-dehydrocholesterol/cholestcrol ratio was 25-64% lower in plasma, brain, and liver of male compared with female rats. This difference achieved statistical significance (p<().01) in plasma and liver only.
DISCUSSION
To our knowledge, this is the first report on brain steroi measurement in the AY mtKlel of atypical absence seizures. Our results indicate that in this model, there is a significant reduction in cholesterol and increase in 7-dehydrocholesterol in all brain regions examined. Because brain total phospholipids and fatty acid profiles remained unaffected, this .study confirms that, at least within the brain of the developing rat, AY-9944 appears to have a specific effect on cholesterol biosynthesis. However, whether cholesterol reduction or accumulation In both chromatograms, the peaks are the internal standard 5oi-cholestane (5C). cholesterol (CH), which is the only detectable sterol in controls, and 7-dehydrocholesterol (7-DHC), which is the only additional sterol present after AY-9944 treatment.
of 7-dehydrocholesterol during development is directly responsible for the generation of atypical absence seizures remains to be determined.
Our recovery study {experiment 2) indicates that the reduction of brain cholesterol and the elevation of 7-dehydrocholesterol in AY-treated rats is transitory once the AY treatment is stopped. However, the adult rats (P42()) continued to experience atypical absence seizures, which lasted twice as long as at P55. Thus the AY-induced epiJeptiform discbarges are spontaneously recurrent and appear to be life long, but tbe brain sterol changes are not. There seems to be a critical developmental window for AY induction of SWDs, because early treatment with AY-9944 disclosed a more severe SWD duration on the ECoG compared with that of rats treated with AY later in life (13) .
Cholesterol biosynthesis inhibitors were first sbown to induce chronic epileptiform activity in 1978 (14) . Tbis phenomenon was further characterized 12 years later when it was proposed that tbe AY-treated rat could represent a model of absence epilepsy (i.e.. spontaneous, recurrent, absence .seizures) (15) . Subsequently it was demonstrated that a 7-aminobutyric acid (GABA)Breceptor antagonist, CGP-35348 (16), reduced absence seizures in AY-treated rats. We have confirmed these findings, and provided EEG, pharmacologic, and developmental characterization of tbis model. We also demonstrated the increased sensitivity of Long-Evans strain of rats to AY and sbowed a distinctly greater susceptibility to AY-induced SWDs in female rats (1) . Our present data show that the same dose of AY increases the 7-dehydrocholesterol-to-cholesterol ratio more in plasma and liver (but not brain) of females than in males, which helps link the brain sterol changes to seizure severity in this model (1, 2, 10) . Sex differences were reported recently in total cholesterol, low-density and high-density lipoprotein cholesterol in response to antiepileptic medication in male and female patients (17) . Therefore it is conceivable that the greater seizure susceptibility to AY in female rats may relate to gender differences in plasma lipoprotein metabolism or to the different susceptibility to altered brain sterol levels (18) .
Two diseases are associated with perturbed brain cholesterol (i.e.. Niemann-Pick type C and Smith-LemliOpitz syndrome), Niemann-Pick type C is an abnormality of intracellular cholesterol transport (19) , and Smith-Lemli-Opitz syndrome is a genetic deficiency of cholesterol synthesis that adversely affects fetal and neonatal development (20) . However, neither of CH. cholesterol: 7-DHC. 7-dehydrt)i;holesteml, " mg/g or mg/ml lor p!a,sma: mean ± SD (11 = 5 for females and n = 6 for males), ''p < 0.01 versus males. 25 -hydroxycholesterol has been shown to reduce GABAti but not GABA^^ receptor-mediated inhibition selectively (21) . However, nothing is known of the neurologic effects of the brain sterol raised by AY (7-dehydrocholesteroi). Furthermore, cholesterol-derived neurosteroids augment GABA^^ receptor-mediated and inhibit GABA^ receptor-mediated inhibition (22) . Membrane cholesterol has been shown to alter the sensitivity of tbe GABA,^ receptor to GABA (23) . ln addition, there is a cholesterol-recognition site in the peripheral-type benzodia/.epine receptor on mitochondria, wbicb could be altered by postnatal AY treatment (24) . Alternatively. AY could exert an effect on brain unrelated to the ability of this compound to inbibit cbolesterol synthesis. Brain cholesterol is made locally only in the brain (2-'i) and can be experimentally depleted by cbolesterol biosynthesis inhibitors otber than AY 9944 (6.13.26). We are pre.sently comparing tbese inhibitors to assess tbe relative importance of total brain sterol reduction versus a change in the 7-dehydrocholesterol/choiestcrol ratio in .seizures induced by cholesterol biosynthesis inhibitors other than AY.
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